TITLE

Meta-analysis finds antidiabetic drugs lower glucose similarly when added to metformin in type 2 diabetes mellitus

PUB. DATE
May 2010
SOURCE
Formulary;May2010, Vol. 45 Issue 5, p146
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses research into the efficacy of noninsulin antidiabetic drugs in lowering blood glucose in patients with type 2 diabetes mellitus. Clinicians have called into question the diabetes treatment guidelines from the American Diabetes Association and the European Association for the Study of Diabetics. Research has found that different classes of hypoglycemics including thiazolidinediones and glinides, when used in combination with metformin, can effectively lower blood glucose.
ACCESSION #
50736185

 

Related Articles

  • ADA/EASD update type 2 diabetes treatment algorithm.  // PharmacoEconomics & Outcomes News;11/1/2008, Issue 565, p2 

    The article announces that the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have released updated recommendations for the treatment of type II diabetes mellitus. Revisions to the treatment algorithm released in 2006 include the availability of...

  • Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin. Arnolds, Sabine; Dellweg, Sibylle; Clair, Janina; Dain, Marie-Paule; Nauck, Michael A.; Rave, Klaus; Kapitza, Christoph // Diabetes Care;Jul2010, Vol. 33 Issue 7, p1509 

    OBJECTIVE -- To assess the effect of a 4-week adjunctive therapy of exenatide (EXE) (5-10 µg b.i.d.) or sitagliptin (SITA) (100 mg once daily) in response to a standardized breakfast meal challenge in 48 men or women with type 2 diabetes receiving insulin glargine (GLAR) + metformin (MET)....

  • Effect of antihyperglycaemic agents added to metformin and a sulfonylurea in type 2 diabetes.  // Australian Journal of Pharmacy;Nov2011, Vol. 92 Issue 1098, p90 

    The article examines the effect of adding a third antihyperglycaemic drug (AHD) to the ongoing metformin and sulfonylurea medication, when blood glucose control is not achieved in patients with type 2 diabetes. Results of studies conducted to evaluate the effect of AHD on glycemic control and...

  • Correlation between changes of blood pressure with insulin resistance in type 2 diabetes mellitus with 4 weeks of pioglitazone therapy. Hettihewa, L. M.; Jayasinghe, S. S.; Imendra, K. G.; Weerarathna, T. P. // International Journal of Diabetes in Developing Countries;Jan-Mar2008, Vol. 28 Issue 1, p26 

    Objective: To examine effects of pioglitazone (PIO) on systolic, diastolic, pulse and mean blood pressures (SBP, DBP, PP and MP, respectively) in type 2 diabetes mellitus (T2DM).Materials and Methods: One hundred and six normotensive patients with T2DM with mean fasting...

  • Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy. Nathan, David M.; Buse, John B.; Davidson, Mayer B.; Ferrannini, Ele; Holman, Rury R.; Sherwin, Robert; Zinman, Bernard // Diabetes Care;Jan2008, Vol. 31 Issue 1, p173 

    The article offers information on a study regarding the management of hyperglycemia in type 2 diabetes. The major features of a consensus algorithm developed for the disease was endorsed by the authors including the need to achieve and maintain glycemia within or as close to the nondiabetic...

  • Exenatide: A New Promising Antidiabetic Agent. CHAKRABORTI, C. K. // Indian Journal of Pharmaceutical Sciences;Jan/Feb2010, Vol. 72 Issue 1, p1 

    Exenatide is a unique agent which can effectively control blood glucose levels in type 2 diabetes mellitus without producing dangerous adverse effects. In addition, it can lower body weight which is very essential for the treatment of obese type 2 diabetes mellitus patients. Since it can delay...

  • hypoglycaemics, oral. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p401 

    An encyclopedia entry for "oral hypoglycaemics" is presented. They refer to a group of antidiabetic drugs that are used for reducing the blood glucose levels of people with type 2 diabetes mellitus. The different modes of action of such drugs, such as sulphonylurea, metformin and guar gum, are...

  • Therapeutic Goal Attainment According to American Diabetes Association Guidelines in Type 2 Diabetes Mellitus. Rodriguez-Saldaña, Joel; Mann, Rachel; Yin, Donald; Krishnarajah, Girishanthy // Diabetes;Jun2007 Supplement 1, Vol. 56, pA631 

    The article presents the findings of a study which assessed the level of therapeutic goal attainment according to the 2006 guidelines of the American Diabetes Association (ADA) in type 2 diabetes mellitus (T2DM) patients. 78.6% of the subjects were prescribed a sulfonylurea in addition to...

  • Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Inzucchi, Silvio E.; Bergenstal, Richard M.; Buse, John B.; Diamant, Michaela; Ferrannini, Ele; Nauck, Michael; Peters, Anne L.; Tsapas, Apostolos; Wender, Richard; Matthews, David R. // Diabetes Care;Jan2015, Vol. 38 Issue 1, p140 

    The article offers information on hyperglycemia management for type 2 diabetes in the U.S. and updates for 2015. Topics include patient-centered approaches to management, the position statement from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics